Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Stroke 1Recurrence 1Ovarian Neoplasms 1Neurologic Manifestations 1Melanoma 1Margins of Excision 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Inflammatory Breast Neoplasms 1Glioblastoma 1Fallopian Tube Neoplasms 1Communication 1Colorectal Neoplasms 1Caregiver Burden 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Brain Neoplasms 1Brain Injuries, Traumatic 1Brain Injuries 1Advanced Malignant Solid Neoplasm 1

Interventions

Bevacizumab 25Fluorouracil 23Leucovorin 22Cetuximab 22Oxaliplatin 19pembrolizumab 14Specimen Handling 11Irinotecan 10Nivolumab 8Magnetic Resonance Spectroscopy 8Biopsy 7atezolizumab 6fludarabine 5encorafenib 5Pemetrexed 5Panitumumab 5HMPL-013 5Gemcitabine 5Folfox protocol 5Cisplatin 5Carboplatin 5trifluridine tipiracil drug combination 4balstilimab 4Standard of Care 4Immunoglobulin G 4Disulfides 4Cyclophosphamide 4regorafenib 3fludarabine phosphate 3dehydroftorafur 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Palliative Care × 30 days × Clear all
NCT06822530 2026-06-04

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

Fred Hutchinson Cancer Center

Phase NA Enrolling by invitation
682 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡